Clinical trial Recruiting at 1 site Interventional Ages 30 to 85

Digital tech-guided stroke movement training at home or in the lab

Official title: Digital Technology-Informed Stroke Rehabilitation

Run by University of Utah · NCT07698522 · Data updated 2026-11-12

This study tests whether technology-guided movement training after stroke works when done at home versus in a lab.

Quick facts

Study typeInterventional
Ages30 Years to 85 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Utah
Academic / other
Locations1 site (Salt Lake City, Utah)
StatusRecruiting
StartedJuly 27, 2026
Main results expectedDecember 2033
Study endsDecember 2033
Registry record updatedSeptember 24, 2026
Trial IDNCT07698522 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 30–85 years with a stroke at least 6 months prior and mild-to-moderate upper-extremity impairment (Fugl-Meyer U/E 30–50), who can consent and participate.

Probably not a fit

Patients with severe aphasia, high spasticity, other neurological disorders, significant pain, or concurrent occupational therapy may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, controlled feasibility trial compares lab-based and home-based movement training guided by digital technologies for people with upper-extremity impairment after stroke. Participants engage in multiple sessions per week for up to 6 weeks, with weekly in-lab movement assessments. Outcomes focus on improvements in movement patterns and differences between the two settings, using a lab-based and a home-based technology approach. Eligible adults aged 30–85 with mild-to-moderate impairment (Fugl-Meyer U/E 30–50) and adequate cognitive function can participate, with restrictions for comorbid conditions and concurrent therapies.

Why it matters

Potential benefit: If successful, patients may achieve better upper-extremity movement through accessible technology-guided training.

How similar studies have gone: Previous tech-guided rehabilitation studies suggest feasibility and potential benefits, but direct lab vs. home comparison in this context is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 30-85 years.
* Diagnosis of stroke.
* Stroke onset of at least six months prior to the time of participation.
* Fugl Meyer Upper Extremity between 30-50 (mild-moderate)
* Cognitive skills to consent and actively participate, as indicated by scores of ≥ 24 on the Mini- Mental Status Examination
* Able to visit lab up to 5x per week for 3 weeks

Exclusion Criteria:

* Presence of severe aphasia preventing the ability to follow 1-step directions at least 80% of the time.
* Excessive spasticity of the wrist, elbow, and shoulder, defined as a Modified Ashworth Score \>2.
* Diagnosis of neurological disorders other than stroke.
* Orthopedic/musculoskeletal conditions (e.g., severe arthritis) affecting the upper extremity.
* Currently or planning to become pregnant.
* Participation in concurrent occupational therapy.
* Unilateral neglect, defined as failure of the Line Bisection Task
* Upper extremity pain \>= 7/10 on Numeric Rating Scale

Where it's running

  • Kennecott Mechanical Engineering Building
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.